John T. Carpenter

6.1k total citations · 1 hit paper
64 papers, 2.7k citations indexed

About

John T. Carpenter is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, John T. Carpenter has authored 64 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 15 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in John T. Carpenter's work include Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (14 papers) and Breast Lesions and Carcinomas (6 papers). John T. Carpenter is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (14 papers) and Breast Lesions and Carcinomas (6 papers). John T. Carpenter collaborates with scholars based in United States, Puerto Rico and Pakistan. John T. Carpenter's co-authors include Robert B. Diasio, Barry Harris, James F. Holland, Richard L. Schilsky, Donald A. Berry, Hyman B. Muss, Silvana Martino, Constance Cirrincione, Larry Norton and James N. Ingle and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer.

In The Last Decade

John T. Carpenter

53 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

2003 921 citations I. Craig Henderson, Donald A. Berry et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John T. Carpenter United States	21	1.7k	1.0k	484	388	361	64	2.7k
Katherine H. R. Tkaczuk United States	21	1.8k 1.0×	968 1.0×	436 0.9×	259 0.7×	387 1.1×	47	2.8k
R.D. Rubens United Kingdom	28	1.3k 0.8×	625 0.6×	426 0.9×	246 0.6×	453 1.3×	53	2.3k
Richard A. Bender United States	22	857 0.5×	514 0.5×	587 1.2×	257 0.7×	260 0.7×	69	1.9k
P.F. Bruning Netherlands	21	1.3k 0.7×	522 0.5×	322 0.7×	158 0.4×	311 0.9×	55	2.2k
Douglas E. Merkel United States	18	1.2k 0.7×	675 0.7×	337 0.7×	417 1.1×	430 1.2×	26	2.2k
Peter J. Rosen United States	29	1.1k 0.6×	585 0.6×	870 1.8×	616 1.6×	740 2.0×	100	2.9k
Gary N. Schwartz United States	29	1.3k 0.7×	1.2k 1.1×	944 2.0×	470 1.2×	1.0k 2.8×	89	3.7k
Pax H.B. Willemse Netherlands	39	1.6k 0.9×	616 0.6×	766 1.6×	488 1.3×	459 1.3×	110	4.2k
E. Terzoli Italy	29	1.9k 1.1×	531 0.5×	342 0.7×	130 0.3×	644 1.8×	102	2.8k
So‐Youn Jung South Korea	32	1.3k 0.8×	1.2k 1.1×	391 0.8×	758 2.0×	427 1.2×	144	2.7k

Countries citing papers authored by John T. Carpenter

Since Specialization

Citations

This map shows the geographic impact of John T. Carpenter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. Carpenter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. Carpenter more than expected).

Fields of papers citing papers by John T. Carpenter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John T. Carpenter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. Carpenter. The network helps show where John T. Carpenter may publish in the future.

Co-authorship network of co-authors of John T. Carpenter

This figure shows the co-authorship network connecting the top 25 collaborators of John T. Carpenter. A scholar is included among the top collaborators of John T. Carpenter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John T. Carpenter. John T. Carpenter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carpenter, John T., Andres Forero, Carla I. Falkson, et al.. (2020). Less Toxic Chemotherapy in Locally Advanced Breast Cancer. Southern Medical Journal. 113(11). 559–563. 2 indexed citations

Connolly, Roisín M., Mary Jo Fackler, Zhe Zhang, et al.. (2017). Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008. Breast Cancer Research and Treatment. 167(1). 107–116. 16 indexed citations

Mehta, Amitkumar & John T. Carpenter. (2013). How Do I Recommend Extended Adjuvant Hormonal Therapy?. Current Treatment Options in Oncology. 15(1). 55–62. 2 indexed citations

Anders, Carey K., Allison M. Deal, Vandana G. Abramson, et al.. (2013). TBCRC 018: Phase II study of iniparib plus chemotherapy to treat triple-negative breast cancer (TNBC) central nervous system (CNS) metastases (mets).. Journal of Clinical Oncology. 31(15_suppl). 515–515. 3 indexed citations

Umphrey, Heidi, W K Bernreuter, K Bland, et al.. (2012). Abstract P3-03-03: A tri-modality imaging assessment algorithm to evaluate neoadjuvant therapy response in patients with operable breast cancer. Cancer Research. 72(24_Supplement). P3–3. 2 indexed citations

Santos, Jennifer De Los, Wanda K. Bernreuter, K.S. Keene, et al.. (2011). Accuracy of Breast Magnetic Resonance Imaging in Predicting Pathologic Response in Patients Treated With Neoadjuvant Chemotherapy. Clinical Breast Cancer. 11(5). 312–319. 31 indexed citations

Kang, Duck-Hee, et al.. (2011). Dose Effects of Relaxation Practice on Immune Responses in Women Newly Diagnosed With Breast Cancer: An Exploratory Study. Oncology nursing forum. 38(3). E240–E252. 17 indexed citations

Forero‐Torres, Andres, Mansoor N. Saleh, J. Galleshaw, et al.. (2010). Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor— or Progesterone Receptor—Positive Breast Cancer. Clinical Breast Cancer. 10(4). 275–280. 29 indexed citations

Carpenter, John T.. (2007). By Brush or Block Printing: Transmitting Cultural Heritage in Premodern Japan. SOAS Research Online (SOAS University of London). 38(8). 57–66.

10.

Henderson, I. Craig, Donald A. Berry, George D. Demetri, et al.. (2003). Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer. Journal of Clinical Oncology. 21(6). 976–983. 921 indexed citations breakdown →

11.

Carpenter, John T., et al.. (1995). The use of anthracyclines in the adjuvant treatment of breast cancer. Cancer Treatment Reviews. 21(3). 199–214. 2 indexed citations

12.

Harris, Barry, John T. Carpenter, & Robert B. Diasio. (1991). Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome. Cancer. 68(3). 499–501. 183 indexed citations

13.

Levine, Ellen G., James M. Raczynski, & John T. Carpenter. (1991). Weight gain with breast cancer adjuvant treatment. Cancer. 67(7). 1954–1959. 79 indexed citations

14.

Carpenter, John T., et al.. (1989). A most excellent instruction for the exact and perfect keeping merchants bookes of accounts ... 1632 . Amphithalami, or, The accomptants closet ... 1660. 1 indexed citations

15.

Carpenter, John T.. (1988). Progestational Agents in the Treatment of Breast Cancer. Cancer treatment and research. 39. 147–156. 2 indexed citations

16.

Rodu, Brad, John T. Carpenter, & Marsha Jones. (1988). The pathogenesis and clinical significance of cytologically detectable oralCandida in acute leukemia. Cancer. 62(9). 2042–2046. 24 indexed citations

17.

Diasio, Robert B., et al.. (1988). Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.. Journal of Clinical Investigation. 81(1). 47–51. 399 indexed citations

18.

Carpenter, John T., et al.. (1988). A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for breast cancer.. Journal of Clinical Oncology. 6(9). 1397–1400. 15 indexed citations

19.

Carpenter, John T.. (1986). Creating the world : poetry, art, and children. University of Washington Press eBooks. 1 indexed citations

20.

Maddox, William A., John T. Carpenter, Henry L. Laws, et al.. (1983). A Randomized Prospective Trial of Radical (Halsted) Mastectomy Versus Modified Radical Mastectomy in 311 Breast Cancer Patients. Annals of Surgery. 198(2). 207–212. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact